Gyros Expands Asian Distribution to Singapore

11-Jun-2012

Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.

“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently announced collaboration with GE Healthcare for distribution in Japan, China, Taiwan and Hong Kong,” commented Erik Walldén, CEO, Gyros.

Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.
“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our re ... more

Gyros AB announced the completion of a development program initiated to fulfill the requirements of scientists using the Company’s immunoassay platform in the biopharmaceutical industry. The development program has seen the release of a number of software modules and services to augment th ... more

Gyros® AB announced the signing of an exclusive distribution agreement with SCRUM Inc. Under the terms of the agreement, SCRUM will market, sell and fully support the Gyros product range, within the Japanese biopharmaceutical, contract research and contract manufacturing industries.
"We ar ... more

Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.
“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our re ... more

analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.